FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Glennon

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Radioligand Assay

Physiology

Co-author Network

Publications

TOP 3
Krasnodara Cameron; Louis De Felice; Renata Kolanos; Rakesh Vekariya; Richard A Glennon
Erratum to: Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Krasnodara Cameron; Louis De Felice; Renata Kolanos; Rakesh Verkariya; Richard A Glennon
Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Krasnodara N Cameron; Richard A Glennon; Renata Kolanos; Ernesto Solis; Louis J De Felice
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Glennon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Krasnodara Cameron; Louis De Felice; Renata Kolanos; Rakesh Vekariya; Richard A Glennon
Erratum to: Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Psychopharmacology 2013;227(3):501.
2013: Krasnodara Cameron; Louis De Felice; Renata Kolanos; Rakesh Verkariya; Richard A Glennon
Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Psychopharmacology 2013;227(3):493-9.
2013: Krasnodara N Cameron; Richard A Glennon; Renata Kolanos; Ernesto Solis; Louis J De Felice
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
British journal of pharmacology 2013;168(7):1750-7.
2011: Nadezhda German; Malgorzata Dukat; Atul Jain; Jin-Sung Kim; Yilong Ma; Anshul Pandya; Marvin K Schulte; Maegan Weltzin; Richard A Glennon
Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine.
Journal of medicinal chemistry 2011;54(20):7259-67.
2010: Malgorzata Dukat; Anna Wesołowska; Genevieve Alley; Shawquia Young; Galya R Abdrakhmanova; Hernán A Navarro; Richard Young; Richard A Glennon
MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay.
Psychopharmacology 2010;210(4):547-57.
2010: Gianfabio Giorgioni; F Claudi; Sabrina Ruggieri; Massimo Ricciutelli; Giovanni F Palmieri; Antonio Di Stefano; Piera Sozio; Laura S Cerasa; Annalisa Chiavaroli; Claudio Ferrante; Giustino Orlando; Richard A Glennon
Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs.
Bioorganic & medicinal chemistry 2010;18(5):1834-43.
2010: Richard A Glennon; Uma Siripurapu; Bryan L Roth; Renata Kolanos; Mikhail L Bondarev; Donald Sikazwe; Mase Lee; Malgorzata Dukat
The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs.
Current topics in medicinal chemistry 2010;10(5):579-95.
2009: Michael J Keiser; Vincent Setola; John J Irwin; Christian Laggner; Atheir I Abbas; Sandra J Hufeisen; Niels H Jensen; Michael B Kuijer; Roberto C Matos; Thuy B Tran; Ryan Whaley; Richard A Glennon; Jérôme Hert; Kelan L H Thomas; Douglas D Edwards; Brian Shoichet; Bryan L Roth
Predicting new molecular targets for known drugs.
Nature 2009;462(7270):175-81.
2009: Richard Young; Richard A Glennon
S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.
Psychopharmacology 2009;203(2):369-82.
2008: Scott P Runyon; Philip D Mosier; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Journal of medicinal chemistry 2008;51(21):6808-28.
2008: Malgorzata Dukat; Philip D Mosier; Renata Kolanos; Bryan L Roth; Richard A Glennon
Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.
Journal of medicinal chemistry 2008;51(3):603-11.
2008: Richard Young; Richard A Glennon
MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice.
Pharmacology, biochemistry, and behavior 2008;88(3):318-31.
2007: Jin-Sung Kim; Anshul Padnya; Maegan Weltzin; Brian W Edmonds; Marvin K Schulte; Richard A Glennon
Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.
Bioorganic & medicinal chemistry letters 2007;17(17):4855-60.
2007: Malgorzata Dukat; Anna Wesolowska; Richard Young; Richard A Glennon
The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
Pharmacology, biochemistry, and behavior 2007;87(2):203-7.
2007: Abner Nyandege; Renata Kolanos; Bryan L Roth; Richard A Glennon
Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2007;17(6):1691-4.
2007: Richard A Glennon; Richard Young; Malgorzata Dukat; Jean Chang-Fong; Mohamed El-Zahabi
N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats.
Pharmacology, biochemistry, and behavior 2007;86(3):477-84.
2007: Malgorzata Dukat; Richard A Glennon; Shawquia Young
MD-354: what is it good for?
CNS drug reviews 2007;13(1):1-20.
2006: Renata Kolanos; Malgorzata Dukat; Bryan L Roth; Richard A Glennon
Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2006;16(22):5832-5.
2006: Richard A Glennon; Tatiana Bondareva; Richard Young
alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.
Pharmacology, biochemistry, and behavior 2006;85(2):448-53.
2006: Richard Young; Tatiana Bondareva; Anna Wesolowska; Shawquia Young; Richard A Glennon
Effect of the 5-HT(6) serotonin antagonist MS-245 on the actions of (-)nicotine.
Pharmacology, biochemistry, and behavior 2006;85(1):170-7.
2006: Donald Sikazwe; Mikhail L Bondarev; Malgorzata Dukat; Jagadeesh B Rangisetty; Bryan L Roth; Richard A Glennon
Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors.
Journal of medicinal chemistry 2006;49(17):5217-25.
2006: Hanan M Ragab; Jin Sung Kim; Malgorzata Dukat; Hernán A Navarro; Richard A Glennon
Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors.
Bioorganic & medicinal chemistry letters 2006;16(16):4283-6.
2006: Uma Siripurapu; Renata Kolanos; Malgorzata Dukat; Bryan L Roth; Richard A Glennon
Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors.
Bioorganic & medicinal chemistry letters 2006;16(14):3793-6.
2006: Richard Young; Sandor Batkai; Malgorzata Dukat; Richard A Glennon
TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice.
Pharmacology, biochemistry, and behavior 2006;84(1):62-73.
2006: Richard Young; Richard B Rothman; Jagadeesh B Rangisetty; John S Partilla; Malgorzata Dukat; Richard A Glennon
TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) inhibits the consumption of "snacks" in mice.
Pharmacology, biochemistry, and behavior 2006;84(1):74-83.
2006: Richard Young; Tatiana Bondareva; Anna Wesolowska; Richard A Glennon
Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).
Pharmacology, biochemistry, and behavior 2006;83(4):612-7.
2005: Manik R Pullagurla; Uma Siripurapu; Renata Kolanos; Mikhail L Bondarev; Malgorzata Dukat; Vincent Setola; Bryan L Roth; Richard A Glennon
Binding of amine-substituted N1-benzenesulfonylindoles at human 5-HT6 serotonin receptors.
Bioorganic & medicinal chemistry letters 2005;15(23):5298-302.
2005: Tatiana Bondareva; Anna Wesołowska; Malgorzata Dukat; Mase Lee; Richard Young; Richard A Glennon
S(+)- and R(-)N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine.
Pharmacology, biochemistry, and behavior 2005;82(3):531-8.
2005: Richard Young; Nantaka Khorana; Tatiana Bondareva; Richard A Glennon
Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).
Pharmacology, biochemistry, and behavior 2005;82(2):404-10.
2005: Richard A Glennon
Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach.
Mini reviews in medicinal chemistry 2005;5(10):927-40.
2005: Malgorzata Dukat; Anna Ramunno; Rita Banzi; M Imad Damaj; Billy Martin; Richard A Glennon
3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands.
Bioorganic & medicinal chemistry letters 2005;15(19):4308-12.
2005: Carmen Abate; Renata Kolanos; Malgorzata Dukat; Vincent Setola; Bryan L Roth; Richard A Glennon
Interaction of chiral MS-245 analogs at h5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2005;15(15):3510-3.
2005: Anna Ramunno; Malgorzata Dukat; Mase Lee; Richard Young; Mohamed El-Zahabi; M Imad Damaj; Billy Martin; Richard A Glennon
6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.
Bioorganic & medicinal chemistry letters 2005;15(13):3237-40.
2005: Vincent Setola; Malgorzata Dukat; Richard A Glennon; Bryan L Roth
Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.
Molecular pharmacology 2005;68(1):20-33.
2005: Renata Kolanos; Uma Siripurapu; Manik R Pullagurla; Mohamed Riaz; Vincent Setola; Bryan L Roth; Malgorzata Dukat; Richard A Glennon
Binding of isotryptamines and indenes at h5-HT6 serotonin receptors.
Bioorganic & medicinal chemistry letters 2005;15(8):1987-91.
2005: Mase Lee; Jagadeesh B Rangisetty; Manik R Pullagurla; Malgorzata Dukat; Vincent Setola; Bryan L Roth; Richard A Glennon
1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
Bioorganic & medicinal chemistry letters 2005;15(6):1707-11.
2004: Richard A Glennon; Mikhail L Bondarev; Nantaka Khorana; Richard Young; Jesse A May; Mark R Hellberg; Marsha A McLaughlin; Najam A Sharif
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Journal of medicinal chemistry 2004;47(24):6034-41.
2004: Thomas E Prisinzano; Malgorzata Dukat; Ho Law; Abdelmalik Slassi; Neil MacLean; Inés DeLannoy; Richard A Glennon
2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(18):4697-9.
2004: Manik R Pullagurla; Richard B Westkaemper; Richard A Glennon
Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors.
Bioorganic & medicinal chemistry letters 2004;14(17):4569-73.
2004: Nantaka Khorana; Manik R Pullagurla; Malgorzata Dukat; Richard Young; Richard A Glennon
Stimulus effects of three sulfur-containing psychoactive agents.
Pharmacology, biochemistry, and behavior 2004;78(4):821-6.
2004: Malgorzata Dukat; Mohamed Taroua; Abdelaziz Dahdouh; Uma Siripurapu; M Imad Damaj; Billy R Martin; Richard A Glennon
(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.
Bioorganic & medicinal chemistry letters 2004;14(14):3651-4.
2004: Nantaka Khorana; Manik R Pullagurla; Richard Young; Richard A Glennon
Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization.
Drug and alcohol dependence 2004;74(3):281-7.
2004: Manik R Pullagurla; Tatiana Bondareva; Richard Young; Richard A Glennon
Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245.
Pharmacology, biochemistry, and behavior 2004;78(2):263-8.
2004: Malgorzata Dukat; Carol Smith; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry 2004;12(10):2545-52.
2004: Srinivas Peddi; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).
Bioorganic & medicinal chemistry letters 2004;14(9):2279-83.
2004: Richard A Glennon; Abd M Ismaiel; Seth Ablordeppey; Mahmoud El-Ashmawy; James B Fisher
Thioxanthene-derived analogs as sigma(1) receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(9):2217-20.
2004: Jean Chang-Fong; Jagadeesh B Rangisetty; Malgorzata Dukat; Vincent Setola; Thomas Raffay; Bryan L Roth; Richard A Glennon
1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(8):1961-4.
2004: Richard A Glennon; Malgorzata Dukat
alpha4beta2 nACh receptor pharmacophore models.
Bioorganic & medicinal chemistry letters 2004;14(8):1841-4.
2004: Jean Chang-Fong; Robin J Tyacke; Alice Lau; Julie Westaway; Alan L Hudson; Richard A Glennon
Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(4):1003-5.
2004: Richard A Glennon; Brian Grella; Robin J Tyacke; Alice Lau; Julie Westaway; Alan L Hudson
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry letters 2004;14(4):999-1002.
2004: Richard A Glennon; Brian Grella; Robin J Tyacke; Alice Lau; Julie Westaway; Alan L Hudson
Binding of an imidazopyridoindole at imidazoline I2 receptors.
Bioorganic & medicinal chemistry letters 2004;14(2):527-9.
2004: Deniz Dogruer; Mase Lee; Malgorzata Dukat; M Imad Damaj; Billy R Martin; Richard A Glennon
3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors.
Bioorganic & medicinal chemistry letters 2004;14(2):523-6.
2004: Richard A Glennon
2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.
Progress in medicinal chemistry 2004;42():55-123.
2004: Richard A Glennon; Malgorzata Dukat; Liang Liao
Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models.
Current topics in medicinal chemistry 2004;4(6):631-44.
2003: Srinivas Peddi; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
European journal of pharmacology 2003;482(1-3):335-7.
2003: Brian Grella; Milt Teitler; Carol Smith; Katharine Herrick-Davis; Richard A Glennon
Binding of beta-carbolines at 5-HT(2) serotonin receptors.
Bioorganic & medicinal chemistry letters 2003;13(24):4421-5.
2003: Robin J Tyacke; Alice Lau; Brian Grella; Richard A Glennon; David J Nutt; Alan L Hudson
Investigation of the affinities of two new beta-carbolines for rat brain imidazoline(2) receptors.
Annals of the New York Academy of Sciences 2003;1009():361-3.
2003: Manik R Pullagurla; Malgorzata Dukat; Vincent Setola; Bryan L Roth; Richard A Glennon
N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates.
Bioorganic & medicinal chemistry letters 2003;13(19):3355-9.
2003: Richard A Glennon; Maha Khalifa Daoud; Malgorzata Dukat; Milt Teitler; Katharine Herrick-Davis; Atul Purohit; Hasan Syed
Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: a QSAR study.
Bioorganic & medicinal chemistry 2003;11(20):4449-54.
2003: Richard B Rothman; Nga Vu; John S Partilla; Bryan L Roth; Sandra J Hufeisen; Beth A Compton-Toth; Jon Birkes; Richard Young; Richard A Glennon
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.
The Journal of pharmacology and experimental therapeutics 2003;307(1):138-45.
2003: Rahime Simsek; Jean Chang-Fong; Mase Lee; Malgorzata Dukat; M Imad Damaj; Billy R Martin; Richard A Glennon
Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents.
Bioorganic & medicinal chemistry letters 2003;13(17):2917-20.
2003: Nantaka Khorana; Carol Smith; Katharine Herrick-Davis; Atul Purohit; Milt Teitler; Brian Grella; Malgorzata Dukat; Richard A Glennon
Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
Journal of medicinal chemistry 2003;46(18):3930-7.
2003: Srinivas Peddi; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.
Bioorganic & medicinal chemistry letters 2003;13(15):2565-8.
2003: Mikhail L Bondarev; Tatiana Bondareva; Richard Young; Richard A Glennon
Behavioral and biochemical investigations of bupropion metabolites.
European journal of pharmacology 2003;474(1):85-93.
2003: Richard A Glennon
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Journal of medicinal chemistry 2003;46(14):2795-812.
2003: Justin R Eckler; Jean Chang-Fong; Richard A Rabin; C Smith; Milt Teitler; Richard A Glennon; Jerrold C Winter
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
Pharmacology, biochemistry, and behavior 2003;75(4):845-52.
2003: Malgorzata Dukat; Richard A Glennon
Epibatidine: impact on nicotinic receptor research.
Cellular and molecular neurobiology 2003;23(3):365-78.
2003: Vincent Setola; Sandra J Hufeisen; K Jane Grande-Allen; Ivan Vesely; Richard A Glennon; Bruce Blough; Richard B Rothman; Bryan L Roth
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
Molecular pharmacology 2003;63(6):1223-9.
2003: Ashraf A Rahman; Maha Khalifa Daoud; Malgorzata Dukat; Katharine Herrick-Davis; Atul Purohit; Milt Teitler; Antonia Taveres do Amaral; Alberto Malvezzi; Richard A Glennon
Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).
Bioorganic & medicinal chemistry letters 2003;13(6):1119-23.
2003: Nantaka Khorana; Atul Purohit; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
gamma-Carbolines: binding at 5-HT5A serotonin receptors.
Bioorganic & medicinal chemistry 2003;11(5):717-22.
2003: G Ferretti; Malgorzata Dukat; Mario Giannella; Alessandro Piergentili; Maria Pigini; Wilma Quaglia; M Imad Damaj; Billy R Martin; Richard A Glennon
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors.
Bioorganic & medicinal chemistry letters 2003;13(4):733-5.
2002: Tatiana Bondareva; Richard Young; Richard A Glennon
Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine.
Pharmacology, biochemistry, and behavior 2002;74(1):157-62.
2002: Malgorzata Dukat; Mohamed El-Zahabi; Giovanni Ferretti; M Imad Damaj; Billy R Martin; Richard Young; Richard A Glennon
(-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine.
Bioorganic & medicinal chemistry letters 2002;12(20):3005-7.
2002: G Ferretti; Malgorzata Dukat; Mario Giannella; Alessandro Piergentili; Maria Pigini; Wilma Quaglia; M Imad Damaj; B R Martin; Richard A Glennon
Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.
Journal of medicinal chemistry 2002;45(21):4724-31.
2002: Mase Lee; Malgorzata Dukat; Liang Liao; Dwight Flammia; M Imad Damaj; Billy Martin; Richard A Glennon
A comparison of the binding of three series of nicotinic ligands.
Bioorganic & medicinal chemistry letters 2002;12(15):1989-92.
2002: Richard B Westkaemper; Richard A Glennon
Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
Current topics in medicinal chemistry 2002;2(6):575-98.
2002: Richard A Glennon; Kamel Metwally; Malgorzata Dukat; Abd M Ismaiel; Joseph De los Angeles; Jeffery Herndon; Milt Teitler; Nantaka Khorana
Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
Current topics in medicinal chemistry 2002;2(6):539-58.
2002: Richard Young; Richard A Glennon
Nicotine and bupropion share a similar discriminative stimulus effect.
European journal of pharmacology 2002;443(1-3):113-8.
2002: Richard A Glennon; Richard Young; Jagadeesh B Rangisetty
Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline.
Pharmacology, biochemistry, and behavior 2002;72(1-2):379-87.
2002: Richard A Glennon; Richard Young
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats.
Pharmacology, biochemistry, and behavior 2002;72(1-2):307-11.
2002: Malgorzata Dukat; Richard Young; Richard A Glennon
Effect of PMA optical isomers and 4-MTA in PMMA-trained rats.
Pharmacology, biochemistry, and behavior 2002;72(1-2):299-305.
2002: Scott P Runyon; Srinivas Peddi; Jason E Savage; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Journal of medicinal chemistry 2002;45(8):1656-64.
2002: Malgorzata Dukat; Imad M Damaj; Richard Young; Robert Vann; Allan C Collins; Michael J Marks; Billy R Martin; Richard A Glennon
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.
European journal of pharmacology 2002;435(2-3):171-80.
2002: Jean Chang-Fong; James Addo; Malgorzata Dukat; Carol Smith; Nicholas A Mitchell; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors.
Bioorganic & medicinal chemistry letters 2002;12(2):155-8.
2002: Richard Young; Richard A Glennon
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine.
Pharmacology, biochemistry, and behavior 2002;71(1-2):205-13.
2001: S S Hong; Richard Young; Richard A Glennon
Discriminative stimulus properties of alpha-ethyltryptamine optical isomers.
Pharmacology, biochemistry, and behavior 2001;70(2-3):311-6.
2001: Jagadeesh B Rangisetty; Malgorzata Dukat; C S Dowd; Katharine Herrick-Davis; A DuPre; S Gadepalli; Milt Teitler; C R Kelley; Najam A Sharif; Richard A Glennon
1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character.
Journal of medicinal chemistry 2001;44(20):3283-91.
2001: Malgorzata Dukat; Y N Choi; Milt Teitler; A Du Pre; Katharine Herrick-Davis; Carol Smith; Richard A Glennon
The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry letters 2001;11(12):1599-603.
2001: Jagadeesh B Rangisetty; Mikhail L Bondarev; Jean Chang-Fong; Richard Young; Richard A Glennon
PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
Pharmacology, biochemistry, and behavior 2001;69(1-2):261-7.
2001: Scott P Runyon; Jason E Savage; M Taroua; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Bioorganic & medicinal chemistry letters 2001;11(5):655-8.
2001: Thomas E Prisinzano; Ho Law; Malgorzata Dukat; Abdelmalik Slassi; Neil MacLean; Lidia Demchyshyn; Richard A Glennon
Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands.
Bioorganic & medicinal chemistry 2001;9(3):613-9.
2001: Richard B Westkaemper; Scott P Runyon; Jason E Savage; Bryan L Roth; Richard A Glennon
Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
Bioorganic & medicinal chemistry letters 2001;11(4):563-6.
2000: G Ferretti; Malgorzata Dukat; Mario Giannella; Alessandro Piergentili; Maria Pigini; Wilma Quaglia; M Imad Damaj; B R Martin; Richard A Glennon
Chain-lengthened and imidazoline analogues of nicotine.
Bioorganic & medicinal chemistry letters 2000;10(23):2665-8.
2000: Y Tsai; Malgorzata Dukat; Abdelmalik Slassi; Neil MacLean; Lidia Demchyshyn; Jason E Savage; Bryan L Roth; S Hufesein; Mase Lee; Richard A Glennon
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
Bioorganic & medicinal chemistry letters 2000;10(20):2295-9.
2000: C S Dowd; Katharine Herrick-Davis; C Egan; A DuPre; Carol Smith; Milt Teitler; Richard A Glennon
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
Journal of medicinal chemistry 2000;43(16):3074-84.
2000: Mark R Hellberg; J F Stubbins; Richard A Glennon
A preliminary investigation of mesoionic xanthine analogues as inhibitors of platelet aggregation.
Bioorganic & medicinal chemistry 2000;8(8):1917-23.
2000: Richard A Glennon; Malgorzata Dukat; Brian Grella; S Hong; L Costantino; Milt Teitler; Carol Smith; C Egan; K Davis; M V Mattson
Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors.
Drug and alcohol dependence 2000;60(2):121-32.
2000: Richard Young; Richard A Glennon
Stimulus effects of phenylpropanolamine optical isomers in (+)amphetamine-trained rats.
Pharmacology, biochemistry, and behavior 2000;66(3):489-94.
2000: Richard A Glennon; Richard Young
MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin.
Pharmacology, biochemistry, and behavior 2000;66(3):483-8.
2000: Malgorzata Dukat; Richard Young; N N Darmani; B Ahmed; Richard A Glennon
The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay.
Psychopharmacology 2000;150(2):200-7.
2000: Kurt Kristiansen; Wesley K Kroeze; DL Willins; E I Gelber; Jason E Savage; Richard A Glennon; Bryan L Roth
A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
The Journal of pharmacology and experimental therapeutics 2000;293(3):735-46.
2000: Richard A Glennon; Richard Young
(+)Amphetamine-stimulus generalization to an herbal ephedrine product.
Pharmacology, biochemistry, and behavior 2000;65(4):655-8.
2000: Richard A Glennon; Mase Lee; Jagadeesh B Rangisetty; Malgorzata Dukat; Bryan L Roth; Jason E Savage; A McBride; Laura Rauser; Sandra J Hufeisen; DK Lee
2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
Journal of medicinal chemistry 2000;43(5):1011-8.
2000: Richard A Glennon; Malgorzata Dukat
Central nicotinic receptor ligands and pharmacophores.
Pharmaceutica acta Helvetiae 2000;74(2-3):103-14.
1999: Richard Young; Mikhail L Bondarev; Richard A Glennon
An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats.
Drug and alcohol dependence 1999;57(1):1-6.
1999: Richard Young; Malgorzata Dukat; L Malmusi; Richard A Glennon
Stimulus properties of PMMA: effect of optical isomers and conformational restriction.
Pharmacology, biochemistry, and behavior 1999;64(2):449-53.
1999: Richard A Glennon
Arylalkylamine drugs of abuse: an overview of drug discrimination studies.
Pharmacology, biochemistry, and behavior 1999;64(2):251-6.
1999: D Flammia; Malgorzata Dukat; M Imad Damaj; B Martin; Richard A Glennon
Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding.
Journal of medicinal chemistry 1999;42(18):3726-31.
1999: Richard B Westkaemper; Scott P Runyon; Mikhail L Bondarev; Jason E Savage; Bryan L Roth; Richard A Glennon
9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
European journal of pharmacology 1999;380(1):R5-7.
1998: K A Metwally; Malgorzata Dukat; CT Egan; Carol Smith; A DuPre; C B Gauthier; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Journal of medicinal chemistry 1998;41(25):5084-93.
1998: Richard Young; Richard A Glennon
Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse.
Psychopharmacology 1998;140(3):250-6.
1998: Richard Young; M Gabryszuk; Richard A Glennon
(-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects.
Pharmacology, biochemistry, and behavior 1998;61(2):169-73.
1998: Richard Young; Richard A Glennon
Discriminative stimulus properties of (-)ephedrine.
Pharmacology, biochemistry, and behavior 1998;60(3):771-5.
1998: Ho Law; Malgorzata Dukat; Milt Teitler; DK Lee; L Mazzocco; Rajender K Kamboj; V Rampersad; Thomas E Prisinzano; Richard A Glennon
Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
Journal of medicinal chemistry 1998;41(13):2243-51.
1998: Brian Grella; Malgorzata Dukat; Richard Young; Milt Teitler; Katharine Herrick-Davis; C B Gauthier; Richard A Glennon
Investigation of hallucinogenic and related beta-carbolines.
Drug and alcohol dependence 1998;50(2):99-107.
1998: CT Egan; Katharine Herrick-Davis; K Miller; Richard A Glennon; Milt Teitler
Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
Psychopharmacology 1998;136(4):409-14.
1998: M Imad Damaj; M Fei-Yin; Malgorzata Dukat; W Glassco; Richard A Glennon; Billy R Martin
Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
The Journal of pharmacology and experimental therapeutics 1998;284(3):1058-65.
1997: Abd M Ismaiel; Malgorzata Dukat; Ho Law; Rajender K Kamboj; E Fan; DK Lee; L Mazzocco; D Buekschkens; Milt Teitler; M E Pierson; Richard A Glennon
2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
Journal of medicinal chemistry 1997;40(26):4415-9.
1997: Richard A Glennon; Richard Young; Malgorzata Dukat; Y Cheng
Initial characterization of PMMA as a discriminative stimulus.
Pharmacology, biochemistry, and behavior 1997;57(1-2):151-8.
1997: Richard Young; Richard A Glennon
Cocaine--stimulus generalization to MDA optical isomers: a reevaluation.
Pharmacology, biochemistry, and behavior 1997;57(1-2):115-8.
1997: Richard Young; Nissar A Darmani; E L Elder; D Dumas; Richard A Glennon
Clobenzorex: evidence for amphetamine-like behavioral actions.
Pharmacology, biochemistry, and behavior 1997;56(2):311-6.
1996: Malgorzata Dukat; A A Abdel-Rahman; A M Ismaiel; S Ingher; Milt Teitler; Laszlo Gyermek; Richard A Glennon
Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors.
Journal of medicinal chemistry 1996;39(20):4017-26.
1996: Richard Young; Richard A Glennon
A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA.
The Journal of pharmacology and experimental therapeutics 1996;276(2):594-601.
1996: Richard A Glennon; S S Hong; M Bondarev; Ho Law; Malgorzata Dukat; S Rakhi; P Power; E Fan; D Kinneau; Rajender K Kamboj; Milt Teitler; Katharine Herrick-Davis; C Smith
Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Journal of medicinal chemistry 1996;39(1):314-22.
1996: Richard A Glennon; Malgorzata Dukat; R B Westkaemper; A M Ismaiel; D G Izzarelli; E M Parker
The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
Molecular pharmacology 1996;49(1):198-206.
1995: Richard A Glennon; Richard Young; Billy R Martin; T A Dal Cason
Methcathione ("cat"): an enantiomeric potency comparison.
Pharmacology, biochemistry, and behavior 1995;50(4):601-6.
1995: A M Ismaiel; K Arruda; Milt Teitler; Richard A Glennon
Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding.
Journal of medicinal chemistry 1995;38(7):1196-202.
1995: M S Choudhary; N Sachs; A Uluer; Richard A Glennon; R B Westkaemper; Bryan L Roth
Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
Molecular pharmacology 1995;47(3):450-7.
1994: Richard A Glennon; S S Hong; Malgorzata Dukat; Milt Teitler; K Davis
5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist.
Journal of medicinal chemistry 1994;37(18):2828-30.
1994: Richard A Glennon; Malgorzata Dukat; M el-Bermawy; Ho Law; J De los Angeles; Milt Teitler; A King; Katharine Herrick-Davis
Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines.
Journal of medicinal chemistry 1994;37(13):1929-35.
1994: Richard A Glennon; S Y Ablordeppey; A M Ismaiel; M B el-Ashmawy; JB Fischer; K B Howie
Structural features important for sigma 1 receptor binding.
Journal of medicinal chemistry 1994;37(8):1214-9.
1994: R B Westkaemper; Richard A Glennon
Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
NIDA research monograph 1994;146():263-83.
1994: Richard A Glennon
Classical hallucinogens: an introductory overview.
NIDA research monograph 1994;146():4-32.
1994: M Imad Damaj; Richard A Glennon; Billy R Martin
Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice.
Brain research bulletin 1994;33(2):199-203.
1993: Richard A Glennon
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
Pharmacology, biochemistry, and behavior 1993;46(2):459-62.
1993: A M Ismaiel; J De Los Angeles; Milt Teitler; S Ingher; Richard A Glennon
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
Journal of medicinal chemistry 1993;36(17):2519-25.
1993: Richard A Glennon; Richard Young; J L Herndon
Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs.
Pharmacology, biochemistry, and behavior 1993;45(4):865-9.
1993: Richard Young; Richard A Glennon
Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex.
Pharmacology, biochemistry, and behavior 1993;45(1):229-31.
1992: J L Herndon; A Ismaiel; S P Ingher; Milt Teitler; Richard A Glennon
Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
Journal of medicinal chemistry 1992;35(26):4903-10.
1992: Richard A Glennon; R Higgs; Richard Young; H Issa
Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists.
Pharmacology, biochemistry, and behavior 1992;43(4):1099-106.
1992: Richard A Glennon; R Higgs
Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline.
Pharmacology, biochemistry, and behavior 1992;43(3):759-63.
1992: J L Herndon; M E Pierson; Richard A Glennon
Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
Pharmacology, biochemistry, and behavior 1992;43(3):739-48.
1992: N A Darmani; Billy R Martin; Richard A Glennon
Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.
The Journal of pharmacology and experimental therapeutics 1992;262(2):692-8.
1992: N A Darmani; Billy R Martin; Richard A Glennon
Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Pharmacology, biochemistry, and behavior 1992;41(3):519-27.
1992: R Young; Richard A Glennon
Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
European journal of pharmacology 1992;212(1):117-9.
1992: Richard A Glennon; R Raghupathi; P Bartyzel; Milt Teitler; S Leonhardt
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
Journal of medicinal chemistry 1992;35(4):734-40.
1992: Richard A Glennon; Richard Young; Malgorzata Dukat
5-HT3 agonist 2-methylserotonin as a training drug in discrimination studies.
Pharmacology, biochemistry, and behavior 1992;41(2):361-4.
1992: Richard A Glennon; Milt Teitler; E Sanders-Bush
Hallucinogens and serotonergic mechanisms.
NIDA research monograph 1992;119():131-5.
1991: R B Westkaemper; Richard A Glennon
Approaches to molecular modeling studies and specific application to serotonin ligands and receptors.
Pharmacology, biochemistry, and behavior 1991;40(4):1019-31.
1991: Richard A Glennon; Malgorzata Dukat
Serotonin receptors and their ligands: a lack of selective agents.
Pharmacology, biochemistry, and behavior 1991;40(4):1009-17.
1991: Richard A Glennon; M Y Yousif; A M Ismaiel; M B el-Ashmawy; J L Herndon; JB Fischer; A C Server; K J Howie
Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands.
Journal of medicinal chemistry 1991;34(12):3360-5.
1991: R K Raghupathi; L Rydelek-Fitzgerald; Milt Teitler; Richard A Glennon
Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity.
Journal of medicinal chemistry 1991;34(8):2633-8.
1991: Richard A Glennon; A M Ismaiel; J D Smith; M Yousif; M el-Ashmawy; J L Herndon; JB Fischer; K J Howie; A C Server
Binding of substituted and conformationally restricted derivatives of N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at sigma-receptors.
Journal of medicinal chemistry 1991;34(6):1855-9.
1991: Richard A Glennon; J D Smith; A M Ismaiel; M el-Ashmawy; G Battaglia; JB Fischer
Identification and exploitation of the sigma-opiate pharmacophore.
Journal of medicinal chemistry 1991;34(3):1094-8.
1991: N A Darmani; Billy R Martin; U Pandey; Richard A Glennon
Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors.
Pharmacology, biochemistry, and behavior 1991;38(2):353-7.
1991: Richard A Glennon; N A Darmani; Billy R Martin
Multiple populations of serotonin receptors may modulate the behavioral effects of serotonergic agents.
Life sciences 1991;48(26):2493-8.
1991: Richard A Glennon
Discriminative stimulus properties of hallucinogens and related designer drugs.
NIDA research monograph 1991;(116):25-44.
1990: Richard A Glennon; J De Vry; D G Spencer; T Glaser
Stimulus properties of tiflucarbine: a novel antidepressant agent.
Pharmacology, biochemistry, and behavior 1990;37(4):769-71.
1990: R A Higgs; Richard A Glennon
Stimulus properties of ring-methyl amphetamine analogs.
Pharmacology, biochemistry, and behavior 1990;37(4):835-7.
1990: L Rydelek-Fitzgerald; Milt Teitler; P W Fletcher; A M Ismaiel; Richard A Glennon
NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Brain research 1990;532(1-2):191-6.
1990: N M Appel; W M Mitchell; R K Garlick; Richard A Glennon; Milt Teitler; E B De Souza
Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
The Journal of pharmacology and experimental therapeutics 1990;255(2):843-57.
1990: Richard A Glennon; G Battaglia; J D Smith
(-)PPAP: a new and selective ligand for sigma binding sites.
Pharmacology, biochemistry, and behavior 1990;37(3):557-9.
1990: Richard A Glennon; C Chaurasia; M Titeler
Binding of indolylalkylamines at 5-HT2 serotonin receptors: examination of a hydrophobic binding region.
Journal of medicinal chemistry 1990;33(10):2777-84.
1990: Richard A Glennon
Do classical hallucinogens act as 5-HT2 agonists or antagonists?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(5-6):509-17.
1990: M Y Yousif; R L Fitzgerald; N Narasimhachari; John A Rosecrans; R V Blanke; Richard A Glennon
Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats.
Drug and alcohol dependence 1990;26(2):127-35.
1990: N A Darmani; Billy R Martin; Richard A Glennon
Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.
European journal of pharmacology 1990;186(1):115-8.
1990: N A Darmani; Billy R Martin; U Pandey; Richard A Glennon
Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions.
Pharmacology, biochemistry, and behavior 1990;37(1):95-9.
1990: N A Darmani; Billy R Martin; U Pandey; Richard A Glennon
Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Pharmacology, biochemistry, and behavior 1990;36(4):901-6.
1990: M R Seggel; M Y Yousif; R A Lyon; M Titeler; Bryan L Roth; E A Suba; Richard A Glennon
A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors.
Journal of medicinal chemistry 1990;33(3):1032-6.
1990: Richard A Glennon; B Misenheimer
Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh").
Pharmacology, biochemistry, and behavior 1990;35(3):517-21.
1990: A M Ismaiel; M Titeler; K J Miller; T S Smith; Richard A Glennon
5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
Journal of medicinal chemistry 1990;33(2):755-8.
1990: Milt Teitler; S Leonhardt; N M Appel; E B De Souza; Richard A Glennon
Receptor pharmacology of MDMA and related hallucinogens.
Annals of the New York Academy of Sciences 1990;600():626-38; discussion 638-9.
1990: Richard A Glennon
Phenylalkylamine stimulants, hallucinogens, and designer drugs.
NIDA research monograph 1990;105():154-60.
1989: Richard A Glennon; A E Ismaiel; B G McCarthy; S J Peroutka
Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study.
European journal of pharmacology 1989;168(3):387-92.
1989: Richard A Glennon; N A Naiman; M E Pierson; J D Smith; A M Ismaiel; M Titeler; R A Lyon
N-(phthalimidoalkyl) derivatives of serotonergic agents: a common interaction at 5-HT1A serotonin binding sites?
Journal of medicinal chemistry 1989;32(8):1921-6.
1989: Richard A Glennon; B R Misenheimer
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
Pharmacology, biochemistry, and behavior 1989;33(4):909-12.
1989: R L Fitzgerald; R V Blanke; Richard A Glennon; M Y Yousif; John A Rosecrans; Alphonse Poklis
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood.
Journal of chromatography 1989;490(1):59-69.
1989: M E Pierson; R A Lyon; M Titeler; S B Schulman; P Kowalski; Richard A Glennon
Design and synthesis of propranolol analogues as serotonergic agents.
Journal of medicinal chemistry 1989;32(4):859-63.
1989: Richard A Glennon
Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships.
NIDA research monograph 1989;94():43-67.
1989: R L Fitzgerald; R V Blanke; John A Rosecrans; Richard A Glennon
Stereochemistry of the metabolism of MDMA to MDA.
Life sciences 1989;45(4):295-301.
1989: N Naiman; R A Lyon; A E Bullock; L T Rydelek; M Titeler; Richard A Glennon
2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
Journal of medicinal chemistry 1989;32(1):253-6.
1988: Richard A Glennon; N A Naiman; R A Lyon; M Titeler
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.
Journal of medicinal chemistry 1988;31(10):1968-71.
1988: Richard A Glennon; N A Naiman; M E Pierson; M Titeler; R A Lyon; E Weisberg
NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
European journal of pharmacology 1988;154(3):339-41.
1988: Richard A Glennon; A E Ismaiel; B Martin; D Poff; M Sutton
A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine.
Pharmacology, biochemistry, and behavior 1988;31(1):9-13.
1988: Richard A Glennon; M Titeler; R A Lyon
A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
Pharmacology, biochemistry, and behavior 1988;30(3):597-601.
1988: Richard A Glennon; M Titeler; R A Lyon; R M Slusher
N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
Journal of medicinal chemistry 1988;31(4):867-70.
1988: Richard A Glennon; M Yousif; G Patrick
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
Pharmacology, biochemistry, and behavior 1988;29(3):443-9.
1988: R A Lyon; M Titeler; M R Seggel; Richard A Glennon
Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.
European journal of pharmacology 1988;145(3):291-7.
1988: Richard A Glennon; M R Seggel; William H Soine; Katharine Herrick-Davis; R A Lyon; M Titeler
[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors.
Journal of medicinal chemistry 1988;31(1):5-7.
1988: M Titeler; R A Lyon; Richard A Glennon
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Psychopharmacology 1988;94(2):213-6.
1988: Richard A Glennon; M E Pierson; J D McKenney
Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine.
Pharmacology, biochemistry, and behavior 1988;29(1):197-9.
1987: M Titeler; R A Lyon; K H Davis; Richard A Glennon
Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Biochemical pharmacology 1987;36(19):3265-71.
1987: John A Rosecrans; Richard A Glennon
The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice.
Pharmacology, biochemistry, and behavior 1987;28(1):39-42.
1987: Richard A Glennon; M Titeler; M R Seggel; R A Lyon
N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
Journal of medicinal chemistry 1987;30(5):930-2.
1987: Richard A Glennon; P J Little; J A Rosecrans; M Yousif
The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice.
Pharmacology, biochemistry, and behavior 1987;26(2):425-6.
1987: Richard Young; Richard A Glennon
Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR).
Psychopharmacology 1987;93(4):529-33.
1987: Richard Young; Richard A Glennon; William L Dewey
Effects of pyrazolopyridines and a triazolopyridazine on the pentobarbital discriminative stimulus.
Psychopharmacology 1987;93(4):494-7.